ArticleWideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques2024
Percutaneous transluminal angioplasty with stenting for the treatment of lower limb arteriosclerosis obliterans.
Article in Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionWith the advancement of minimally invasive techniques, percutaneous transluminal angioplasty with stenting (PTAS) has emerged as a significant treatment approach for lower limb arteriosclerosis obliterans (ASO).
aimThe aim of this study was to evaluate the clinical efficacy of PTAS in patients with lower limb ASO. MATERIALS AND
methodsA total of 96 ASO patients admitted to our hospital between January 2021 and December 2022 were included in this study. They were divided into 2 groups according to the treatment method: the observation group (n = 48) received PTAS treatment, while the control group (n = 48) underwent percutaneous transluminal angioplasty (PTA). Treatment efficacy was evaluated 30 dayspostsurgery. Pre- and postoperative measurements included the ankle-brachial index (ABI), claudication distance, and quality of life scores derived from the 36-Item Short Form Health Survey (SF-36).Postoperative complications and the rate of target lesion revascularization (TLR) were also recorded.
resultsIn the observation group, 29 patients experienced marked improvement and 17 were effectively treated, yielding the total effectiveness rate of 95.83%, which was higher than in the control group (83.33%; P = 0.045). Both groups showed significant improvement in ABI, claudication distance, and SF-36 scores after treatment, with the observation group presenting significantly better results than the control group. There was no difference in the total incidence of complications between the 2 groups (P = 0.24), however, the TLR occurrence rate was lower in the observation group (P = 0.04).
conclusionsThis study highlights the significant benefits of PTAS in the treatment of ASO, including improved overall effectiveness, enhanced functional indicators, and reduced rate of TLR, thus providing strong evidence for clinicians when selecting treatment methods for patients with lower limb ASO.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.